Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Geptanolimab in r/r PMBCL
NCT03639181Phase 2Unknown
- Sponsor
- Genor Biopharma
- Start
- Oct 2018
- Primary completion
- Sep 2021
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of geptanolimab in primary mediastinal large B-cell lymphoma (PMBCL), sponsored by Genor Biopharma. Status: unknown.
02
Drugs
geptanolimab
03
Conditions
primary mediastinal large B-cell lymphoma (PMBCL)
Beyond the preview
Go deeper on NCT03639181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03639181.